HOME Top Market Reports Immunohistochemistry Market by Product (Antibody, Reagent, Kits, Slide Staining System, Tissue Microarray) Application (Diagnostics (Cancer, Cardiovascular, Diabetes, Autoimmune, Infectious Diseases) & Drug Testing) End User - Global Forecast to 2021

Immunohistochemistry Market by Product (Antibody, Reagent, Kits, Slide Staining System, Tissue Microarray) Application (Diagnostics (Cancer, Cardiovascular, Diabetes, Autoimmune, Infectious Diseases) & Drug Testing) End User - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: November 2016
Report Code: BT 4780

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The immunohistochemistry market is projected to reach USD 2.12 Billion by 2021, at a CAGR of 7.3% during the forecast period. Rising geriatric population, growing prevalence of chronic diseases, increasing number of diagnostic centers, and increasing physician awareness & demand for histopathology are expected to fuel the growth of this market in the coming years. However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine offer significant growth opportunities in the market.

The global immunohistochemistry market is segmented based on product, application, end user, and region. Based on product, the market is segmented into antibodies, reagents, equipment, and kits. The antibodies segment is further divided into primary antibodies and secondary antibodies. The reagents segment is further divided into histological stains, blocking sera & reagents, chromogenic substrates, fixation reagents, stabilizers, organic solvents, proteolytic enzymes, and diluents. The equipment segment is further divided into slide staining systems, tissue microarrays, tissue processing systems, scanners, and others.

Based on application, the immunohistochemistry market is segmented into diagnostics and drug testing. The diagnostics segment is further divided into cancer, infectious diseases, cardiovascular diseases, autoimmune diseases, diabetes mellitus, and nephrological diseases.

Based on end user, the market is segmented into hospitals & diagnostic laboratories, research institutions, and other end users. This report also provides market information across major regional segments, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These regions are further segmented at a country level.

The markets in Asia-Pacific, Latin America, and the Middle East & Africa are expected to register high growth during the forecast period owing to the presence of a large pool of cancer patients, increasing healthcare expenditure, rapidly developing healthcare infrastructure, increasing per capita income, and increasing prevalence of chronic diseases in emerging countries in this region. Developing countries such as India, China, and Brazil will be the focal point of growth in these respective regional markets.

The global immunohistochemistry market is consolidated at the top. Small market players operating at regional and local levels are challenging the market shares of leading players. In order to maintain their market shares, leading players are continuously developing new technologies and upgrading their existing products to enhance their product portfolios. Increasing competition in this market is expected to drive innovation, thereby helping the industry to overcome existing challenges and at the same time address compliance issues and demand of end users.

Target Audience

  • Manufacturing Companies of Immunohistochemistry Products
  • Hospitals and Clinics
  • Nursing Homes
  • Assisted Living Facilities
  • Healthcare Insurance Providers
  • Market Research & Consulting Firms
  • Venture Capitalist and Investors
  • Research Institutes
  • Contract Research Organizations

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

Immunohistochemistry (IHC) is a laboratory test that uses antibodies to test certain antigens in a tissue combining immunological, anatomical, and biochemical techniques. There are multiple approaches and permutation in immunohistochemistry applicable in drug testing and diagnosis of chronic diseases like cancer, infectious diseases, cardiovascular diseases, diabetes, and autoimmune diseases. The market covers the market size from 2014 to 2021.

Global Immunohistochemistry Market

This research report categorizes the immunohistochemistry market into the following segments:

  • Global Immunohistochemistry Market, by Product
    • Antibodies
    • Reagents
    • Equipment
    • Kits
  • Global Immunohistochemistry Market, by Application
    • Diagnostics
      • Cancer
      • Infectious Diseases
      • Cardiovascular diseases
      • Autoimmune Diseases
      • Diabetes mellitus
      • Nephrological Diseases
    • Drug Testing
  • Global immunohistochemistry Market, by End User
    • Hospitals and Diagnostic Laboratories
    • Research Institutes
    • Other End Users (Includes Contract Research Organization and Forensic Laboratories)
  • Global Immunohistochemistry Market, by Region
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • India
      • Rest of Asia-Pacific
    • Rest of the World
      • Latin America
      • Middle East & Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

  • Product Analysis
    • Product matrix which gives a detailed comparison of the product portfolios of the top companies
  • Geographic Analysis
    • Further breakdown of the Rest of Asia-Pacific immunohistochemistry market into South Korea, Australia, New Zealand, and others
    • Further breakdown of the Rest of Europe immunohistochemistry market into Belgium, Russia, Netherlands, Switzerland, and others
  • Company Information
      Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 20)
    1.1 Objectives of the Study
    1.2 Immunohistochemistry Market Definition
    1.3 Immunohistochemistry Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Stakeholders

2 Research Methodology (Page No. - 23)
    2.1 Research Approach
    2.2 Immunohistochemistry Market Size Estimation
    2.3 Immunohistochemistry Market Breakdown and Data Triangulation
    2.4 Immunohistochemistry Market Share Estimation
           2.4.1 Secondary Sources
                    2.4.1.1 Key Data From Secondary Sources
           2.4.2 Primary Sources
                    2.4.2.1 Key Data From Primary Sources
           2.4.3 Key Industry Insights
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 30)

4 Premium Insights (Page No. - 34)
    4.1 Immunohistochemistry: Market Overview
    4.2 Immunohistochemistry Market Size, By Product, 2016 vs 2021
    4.3 Geographic Snapshot of the Immunohistochemistry Market (2015)
    4.4 Immunohistochemistry Market: Geographic Mix
    4.5 Immunohistochemistry Market: Developing vs Developed Countries (2016-2021)

5 Market Overview (Page No. - 37)
    5.1 Introduction
    5.2 Key Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Growing Prevalence of Cancer
                    5.2.1.2 Rapidly Increasing Geriatric Population
                    5.2.1.3 Rapid Technological Developments in the Ivd Industry
                    5.2.1.4 Increasing Healthcare Spending
           5.2.2 Market Restraints
                    5.2.2.1 Limited Reimbursements
                    5.2.2.2 Implementation of Excise Duty By the U.S. Government
           5.2.3 Market Opportunities
                    5.2.3.1 Rapid Growth in the Emerging Markets of APAC and Latin America
                    5.2.3.2 Increasing Demand for Personalized Medicine
           5.2.4 Market Challenge
                    5.2.4.1 Regulatory Restrictions

6 Industry Insights (Page No. - 46)
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 Growing Consolidation of the Immunohistochemistry Market
           6.2.2 Incorporation of Nanotechnology in Immunohistochemistry
           6.2.3 Adoption of Multiplex Arrays
           6.2.4 Automation in Immunohistochemistry Market
    6.3 Regulatory Analysis
           6.3.1 North America
           6.3.2 Europe
           6.3.3 Asia-Pacific

7 Global Immunohistochemistry Market, By Product (Page No. - 53)
    7.1 Introduction
    7.2 Antibodies
           7.2.1 Primary Antibodies
           7.2.2 Secondary Antibodies
    7.3 Equipment
           7.3.1 Slide Staining Systems
           7.3.2 Tissue Microarrays
           7.3.3 Tissue Processing Systems
           7.3.4 Slide Scanners
           7.3.5 Other Equipment
    7.4 Reagents
           7.4.1 Histological Stains
           7.4.2 Blocking Sera and Reagents
           7.4.3 Chromogenic Substrates
           7.4.4 Fixation Reagents
           7.4.5 Stabilizers
           7.4.6 Organic Solvents
           7.4.7 Proteolytic Enzymes
           7.4.8 Diluents
    7.5 Kits

8 Global Immunohistochemistry Market, By Application (Page No. - 78)
    8.1 Introduction
    8.2 Diagnostics
           8.2.1 Cancer
           8.2.2 Infectious Diseases
           8.2.3 Cardiovascular Disease
           8.2.4 Autoimmune Diseases
           8.2.5 Diabetes Mellitus
           8.2.6 Nephrological Diseases
    8.3 Drug Testing

9 Global Immunohistochemistry Market, By End User (Page No. - 90)
    9.1 Introduction
    9.2 Hospitals and Diagnostic Laboratories
    9.3 Research Institutes
    9.4 Other End Users

10 Global Immunohistochemistry Market, By Region (Page No. - 96)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 France
             10.3.3 U.K.
             10.3.4 Italy
             10.3.5 Spain
             10.3.6 Rest of Europe
     10.4 Asia-Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 Rest of Asia-Pacific
     10.5 Rest of the World
             10.5.1 Latin America
             10.5.2 Middle East and Africa

11 Competitive Landscape (Page No. - 165)
     11.1 Overview
     11.2 Market Share Analysis
     11.3 Competitive Situations and Trends
             11.3.1 Product Launches
             11.3.2 Agreements, Partnerships, and Collaborations
             11.3.3 Acquisitions
             11.3.4 Expansions

12 Company Profiles (Page No. - 172)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     12.1 Introduction
     12.2 F. Hoffmann-LA Roche AG
     12.3 Danaher Corporation
     12.4 Agilent Technologies, Inc.
     12.5 Thermo Fisher Scientific Inc.
     12.6 Merck Millipore
     12.7 Bio-Rad Laboratories, Inc.
     12.8 Perkinelmer, Inc.
     12.9 Abcam PLC
     12.10 Cell Signaling Technology, Inc.
     12.11 Bio SB

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 207)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Other Developments
     13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.5 Introducing RT: Real-Time Market Intelligence
     13.6 Available Customizations
     13.7 Related Reports
     13.8 Author Details


List of Tables (181 Tables)

Table 1 Market Drivers: Impact Analysis
Table 2 Market Restraints: Impact Analysis
Table 3 Market Opportunities: Impact Analysis
Table 4 Market Challenge: Impact Analysis
Table 5 Major Acquisitions in the Market, 2014-2016
Table 6 In Vitro Diagnostics Classification for Some Developed Countries
Table 7 Regulations in the Asia-Pacific
Table 8 Global Immunohistochemistry Market Size, By Type, 2014–2021 (USD Million)
Table 9 Global Immunohistochemistry Market Size, By Country, 2014–2021 (USD Million)
Table 10 Global Immunohistochemistry Antibodies Market Size, By Country/Region, 2014–2021 (USD Million)
Table 11 Global Immunohistochemistry Antibodies Market Size, By Type, 2014–2021 (USD Million)
Table 12 Global Primary Antibodies Market Size, By Country/Region, 2014–2021 (USD Million)
Table 13 Global Secondary Antibodies Market Size, By Country/Region, 2014–2021 (USD Million)
Table 14 Global Immunohistochemistry Equipment Market Size, By Type, 2014–2021 (USD Million)
Table 15 Global Immunohistochemistry Equipment Market Size, By Country/Region, 2014–2021 (USD Million)
Table 16 Global Slide Staining Systems Market Size, By Country/Region, 2014–2021 (USD Million)
Table 17 Global Tissue Microarrays Market Size, By Country/Region, 2014–2021 (USD Million)
Table 18 Global Tissue Processing Systems Market Size, By Country/Region, 2014–2021 (USD Million)
Table 19 Global Slide Scanners Market Size, By Country/Region, 2014–2021 (USD Million)
Table 20 Global Other Equipment Market Size, By Country/Region, 2014–2021 (USD Million)
Table 21 Global Immunohistochemistry Reagents Market Size, By Country/Region, 2014–2021 (USD Million)
Table 22 Global Immunohistochemistry Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 23 Global Histological Stains Market Size, By Country/Region, 2014–2021 (USD Million)
Table 24 Global Blocking Sera and Reagents Market Size, By Country/Region, 2014–2021 (USD Million)
Table 25 Global Chromogenic Substrates Market Size, By Country/Region, 2014–2021 (USD Million)
Table 26 Global Fixation Reagents Market Size, By Country/Region, 2014–2021 (USD Million)
Table 27 Global Stabilizers Market Size, By Country/Region, 2014–2021 (USD Million)
Table 28 Global Organic Solvents Market Size, By Country/Region, 2014–2021 (USD Million)
Table 29 Global Proteolytic Enzymes Market Size, By Country/Region, 2014–2021 (USD Million)
Table 30 Global Diluents Market Size, By Country/Region, 2014–2021 (USD Million)
Table 31 Global Immunohistochemistry Kits Market Size, By Country/Region, 2014–2021 (USD Million)
Table 32 Global Immunohistochemistry Market Size, By Application, 2014–2021 (USD Million)
Table 33 Global Immunohistochemistry Market Size for Diagnostic Applications, By Disease, 2014–2021 (USD Million)
Table 34 Global Immunohistochemistry Market Size for Diagnostic Applications, By Country/Region, 2014–2021 (USD Million)
Table 35 Global Immunohistochemistry Market Size for Cancer Diagnosis, By Country/Region, 2014–2021 (USD Million)
Table 36 Global Immunohistochemistry Market Size for Infectious Disease Diagnosis, By Country/Region, 2014–2021 (USD Million)
Table 37 Global Immunohistochemistry Market Size for Cardiovascular Disease Diagnosis, By Country/Region, 2014–2021 (USD Million)
Table 38 Global Immunohistochemistry Market Size for Autoimmune Disease Diagnosis, By Country/Region, 2014–2021 (USD Million)
Table 39 Global Immunohistochemistry Market Size for Diabetes Mellitus Diagnosis, By Country/Region, 2014–2021 (USD Million)
Table 40 Global Immunohistochemistry Market Size for Nephrological Disease Diagnosis, By Country/Region, 2014–2021 (USD Million)
Table 41 Global Immunohistochemistry Market Size for Drug Testing, By Country/Region, 2014–2021 (USD Million)
Table 42 Global Immunohistochemistry Market Size, By End User, 2014–2021 (USD Million)
Table 43 Global Immunohistochemistry Market Size for Hospitals & Diagnostic Laboratories, By Country/Region, 2014–2021 (USD Million)
Table 44 Global Immunohistochemistry Market Size for Research Institutes, By Country/Region, 2014–2021 (USD Million)
Table 45 Global Immunohistochemistry Market Size for Other End Users, By Country/Region, 2014–2021 (USD Million)
Table 46 Global Immunohistochemistry Market Size, By Region, 2014-2021 (USD Million)
Table 47 North America: Immunohistochemistry Market Size, By Country/Region, 2014-2021 (USD Million)
Table 48 North America: Immunohistochemistry Market Size, By Product, 2014-2021 (USD Million)
Table 49 North America: Immunohistochemistry Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 50 North America: Immunohistochemistry Antibodies Market Size, By Type, 2014-2021 (USD Million)
Table 51 North America: Immunohistochemistry Equipment Market Size, By Type, 2014-2021 (USD Million)
Table 52 North America: Immunohistochemistry Market Size, By Application, 2014-2021 (USD Million)
Table 53 North America: Diagnostic Applications Market Size, By Type, 2014-2021 (USD Million)
Table 54 North America: Immunohistochemistry Market Size, By End User, 2014-2021 (USD Million)
Table 55 U.S.: Immunohistochemistry Market Size, By Product, 2014-2021 (USD Million)
Table 56 U.S.: Immunohistochemistry Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 57 U.S.: Immunohistochemistry Antibodies Market Size, By Type, 2014-2021 (USD Million)
Table 58 U.S.: Immunohistochemistry Equipment Market Size, By Type, 2014-2021 (USD Million)
Table 59 U.S.: Immunohistochemistry Market Size, By Application, 2014-2021 (USD Million)
Table 60 U.S.: Diagnostic Applications Market Size, By Type, 2014-2021 (USD Million)
Table 61 U.S.: Immunohistochemistry Market Size, By End User, 2014-2021 (USD Million)
Table 62 Canada: Immunohistochemistry Market Size, By Product, 2014-2021 (USD Million)
Table 63 Canada: Immunohistochemistry Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 64 Canada: Immunohistochemistry Antibodies Market Size, By Type, 2014-2021 (USD Million)
Table 65 Canada: Immunohistochemistry Equipment Market Size, By Type, 2014-2021 (USD Million)
Table 66 Canada: Immunohistochemistry Market Size, By Application, 2014-2021 (USD Million)
Table 67 Canada: Diagnostic Applications Market Size, By Type, 2014-2021 (USD Million)
Table 68 Canada: Immunohistochemistry Market Size, By End User, 2014-2021 (USD Million)
Table 69 Europe: Immunohistochemistry Market Size, By Country, 2014-2021 (USD Million)
Table 70 Europe: Immunohistochemistry Market Size, By Product, 2014-2021 (USD Million)
Table 71 Europe: Immunohistochemistry Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 72 Europe: Immunohistochemistry Antibodies Market Size, By Type, 2014-2021 (USD Million)
Table 73 Europe: Immunohistochemistry Equipment Market Size, By Type, 2014-2021 (USD Million)
Table 74 Europe: Immunohistochemistry Market Size, By Application, 2014-2021 (USD Million)
Table 75 Europe: Diagnostic Applications Market Size, By Type, 2014-2021 (USD Million)
Table 76 Europe: Immunohistochemistry Market Size, By End User, 2014-2021 (USD Million)
Table 77 Germany: Immunohistochemistry Market Size, By Product, 2014-2021 (USD Million)
Table 78 Germany: Immunohistochemistry Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 79 Germany: Immunohistochemistry Antibodies Market Size, By Type, 2014-2021 (USD Million)
Table 80 Germany: Immunohistochemistry Equipment Market Size, By Type, 2014-2021 (USD Million)
Table 81 Germany: Immunohistochemistry Market Size, By Application, 2014-2021 (USD Million)
Table 82 Germany: Diagnostic Applications Market Size, By Type, 2014-2021 (USD Million)
Table 83 Germany: Immunohistochemistry Market Size, By End User, 2014-2021 (USD Million)
Table 84 France: Immunohistochemistry Market Size, By Product, 2014-2021 (USD Million)
Table 85 France: Immunohistochemistry Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 86 France: Immunohistochemistry Antibodies Market Size, By Type, 2014-2021 (USD Million)
Table 87 France: Immunohistochemistry Equipment Market Size, By Type, 2014-2021 (USD Million)
Table 88 France: Immunohistochemistry Market Size, By Application, 2014-2021 (USD Million)
Table 89 France: Diagnostic Applications Market Size, By Type, 2014-2021 (USD Million)
Table 90 France: Immunohistochemistry Market Size, By End User, 2014-2021 (USD Million)
Table 91 U.K.: Immunohistochemistry Market Size, By Product, 2014-2021 (USD Million)
Table 92 U.K.: Immunohistochemistry Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 93 U.K.: Immunohistochemistry Antibodies Market Size, By Type, 2014-2021 (USD Million)
Table 94 U.K.: Immunohistochemistry Equipment Market Size, By Type, 2014-2021 (USD Million)
Table 95 U.K.: Immunohistochemistry Market Size, By Application, 2014-2021 (USD Million)
Table 96 U.K.: Diagnostic Applications Market Size, By Type, 2014-2021 (USD Million)
Table 97 U.K.: Immunohistochemistry Market Size, By End User, 2014-2021 (USD Million)
Table 98 Italy: Immunohistochemistry Market Size, By Product, 2014-2021 (USD Million)
Table 99 Italy: Immunohistochemistry Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 100 Italy: Immunohistochemistry Antibodies Market Size, By Type, 2014-2021 (USD Million)
Table 101 Italy: Immunohistochemistry Equipment Market Size, By Type, 2014-2021 (USD Million)
Table 102 Italy: Immunohistochemistry Market Size, By Application, 2014-2021 (USD Million)
Table 103 Italy: Diagnostic Applications Market Size, By Type, 2014-2021 (USD Million)
Table 104 Italy: Immunohistochemistry Market Size, By End User, 2014-2021 (USD Million)
Table 105 Spain: Immunohistochemistry Market Size, By Product, 2014-2021 (USD Million)
Table 106 Spain: Immunohistochemistry Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 107 Spain: Immunohistochemistry Antibodies Market Size, By Type, 2014-2021 (USD Million)
Table 108 Spain: Immunohistochemistry Equipment Market Size, By Type, 2014-2021 (USD Million)
Table 109 Spain: Immunohistochemistry Market Size, By Application, 2014-2021 (USD Million)
Table 110 Spain: Diagnostic Applications Market Size, By Type, 2014-2021 (USD Million)
Table 111 Spain: Immunohistochemistry Market Size, By End User, 2014-2021 (USD Million)
Table 112 Rest of Europe: Immunohistochemistry Market Size, By Product, 2014-2021 (USD Million)
Table 113 Rest of Europe: Immunohistochemistry Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 114 Rest of Europe: Immunohistochemistry Antibodies Market Size, By Type, 2014-2021 (USD Million)
Table 115 Rest of Europe: Immunohistochemistry Equipment Market Size, By Type, 2014-2021 (USD Million)
Table 116 Rest of Europe: Immunohistochemistry Market Size, By Application, 2014-2021 (USD Million)
Table 117 Rest of Europe: Diagnostic Applications Market Size, By Type, 2014-2021 (USD Million)
Table 118 Rest of Europe: Immunohistochemistry Market Size, By End User, 2014-2021 (USD Million)
Table 119 Asia-Pacific: Immunohistochemistry Market Size, By Country, 2014-2021 (USD Million)
Table 120 Asia-Pacific: Immunohistochemistry Market Size, By Product, 2014-2021 (USD Million)
Table 121 Asia-Pacific: Immunohistochemistry Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 122 Asia-Pacific: Immunohistochemistry Antibodies Market Size, By Type, 2014-2021 (USD Million)
Table 123 Asia-Pacific: Immunohistochemistry Equipment Market Size, By Type, 2014-2021 (USD Million)
Table 124 Asia-Pacific: Immunohistochemistry Market Size, By Application, 2014-2021 (USD Million)
Table 125 Asia-Pacific: Diagnostic Applications Market Size, By Type, 2014-2021 (USD Million)
Table 126 Asia-Pacific: Immunohistochemistry Market Size, By End User, 2014-2021 (USD Million)
Table 127 Japan: Immunohistochemistry Market Size, By Product, 2014-2021 (USD Million)
Table 128 Japan: Immunohistochemistry Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 129 Japan: Immunohistochemistry Antibodies Market Size, By Type, 2014-2021 (USD Million)
Table 130 Japan: Immunohistochemistry Equipment Market Size, By Type, 2014-2021 (USD Million)
Table 131 Japan: Immunohistochemistry Market Size, By Application, 2014-2021 (USD Million)
Table 132 Japan: Diagnostic Applications Market Size, By Type, 2014-2021 (USD Million)
Table 133 Japan: Immunohistochemistry Market Size, By End User, 2014-2021 (USD Million)
Table 134 China: Immunohistochemistry Market Size, By Product, 2014-2021 (USD Million)
Table 135 China: Immunohistochemistry Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 136 China: Immunohistochemistry Antibodies Market Size, By Type, 2014-2021 (USD Million)
Table 137 China: Immunohistochemistry Equipment Market Size, By Type, 2014-2021 (USD Million)
Table 138 China: Immunohistochemistry Market Size, By Application, 2014-2021 (USD Million)
Table 139 China: Diagnostic Applications Market Size, By Type, 2014-2021 (USD Million)
Table 140 China: Immunohistochemistry Market Size, By End User, 2014-2021 (USD Million)
Table 141 India: Immunohistochemistry Market Size, By Product, 2014-2021 (USD Million)
Table 142 India: Immunohistochemistry Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 143 India: Immunohistochemistry Antibodies Market Size, By Type, 2014-2021 (USD Million)
Table 144 India: Immunohistochemistry Equipment Market Size, By Type, 2014-2021 (USD Million)
Table 145 India: Immunohistochemistry Market Size, By Application, 2014-2021 (USD Million)
Table 146 India: Diagnostic Applications Market Size, By Type, 2014-2021 (USD Million)
Table 147 India: Immunohistochemistry Market Size, By End User, 2014-2021 (USD Million)
Table 148 RoAPAC: Immunohistochemistry Market Size, By Product, 2014-2021 (USD Million)
Table 149 RoAPAC: Immunohistochemistry Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 150 RoAPAC: Immunohistochemistry Antibodies Market Size, By Type, 2014-2021 (USD Million)
Table 151 RoAPAC: Immunohistochemistry Equipment Market Size, By Type, 2014-2021 (USD Million)
Table 152 RoAPAC: Immunohistochemistry Market Size, By Application, 2014-2021 (USD Million)
Table 153 RoAPAC: Diagnostic Applications Market Size, By Type, 2014-2021 (USD Million)
Table 154 RoAPAC: Immunohistochemistry Market Size, By End User, 2014-2021 (USD Million)
Table 155 RoW: Immunohistochemistry Market Size, By Region, 2014-2021 (USD Million)
Table 156 RoW: Immunohistochemistry Market Size, By Type, 2014-2021 (USD Million)
Table 157 RoW: Immunohistochemistry Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 158 RoW: Immunohistochemistry Antibodies Market Size, By Type, 2014-2021 (USD Million)
Table 159 RoW: Immunohistochemistry Equipment Market Size, By Type, 2014-2021 (USD Million)
Table 160 RoW: Immunohistochemistry Market Size, By Application, 2014-2021 (USD Million)
Table 161 RoW: Diagnostic Applications Market Size, By Type, 2014-2021 (USD Million)
Table 162 RoW: Immunohistochemistry Market Size, By End User, 2014-2021 (USD Million)
Table 163 Latin America: Immunohistochemistry Market Size, By Product, 2014-2021 (USD Million)
Table 164 Latin America: Immunohistochemistry Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 165 Latin America: Immunohistochemistry Antibodies Market Size, By Type, 2014-2021 (USD Million)
Table 166 Latin America: Immunohistochemistry Equipment Market Size, By Type, 2014-2021 (USD Million)
Table 167 Latin America: Immunohistochemistry Market Size, By Application, 2014-2021 (USD Million)
Table 168 Latin America: Diagnostic Applications Market Size, By Type, 2014-2021 (USD Million)
Table 169 Latin America: Immunohistochemistry Market Size, By End User, 2014-2021 (USD Million)
Table 170 Middle East and Africa: Immunohistochemistry Market Size, By Product, 2014-2021 (USD Million)
Table 171 Middle East and Africa: Immunohistochemistry Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 172 Middle East and Africa: Immunohistochemistry Antibodies Market Size, By Type, 2014-2021 (USD Million)
Table 173 Middle East and Africa: Immunohistochemistry Equipment Market Size, By Type, 2014-2021 (USD Million)
Table 174 Middle East and Africa: Immunohistochemistry Market Size, By Application, 2014-2021 (USD Million)
Table 175 Middle East and Africa: Diagnostic Applications Market Size, By Type, 2014-2021 (USD Million)
Table 176 Middle East and Africa: Immunohistochemistry Market Size, By End User, 2014-2021 (USD Million)
Table 177 Growth Strategy Matrix (2013–2016)
Table 178 Product Launches, 2016
Table 179 Agreements, Partnerships, and Collaborations, 2016
Table 180 Acquisitions, 2015-2016
Table 181 Expansions, 2014-2016


List of Figures (44 Figures)

Figure 1 Global Immunohistochemistry Market
Figure 2 Research Design
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 7 Global Immunohistochemistry Market Size, By Product, 2016 vs 2021 (USD Million)
Figure 8 Global Immunohistochemistry Market Size, By Application, 2016 vs 2021 (USD Million)
Figure 9 Global Immunohistochemistry Market Size, By End User, 2016 vs 2021 (USD Million)
Figure 10 Global Immunohistochemistry Market Size, By Region, 2016 vs 2021
Figure 11 Growth in Geriatric Population and the Subsequent Increase in the Prevalence of Chronic Diseases is Driving Growth in the Immunohistochemistry Market
Figure 12 Antibodies Segment Will Continue to Dominate the Immunohistochemistry Market in 2021
Figure 13 U.S. Accounted for the Largest Share of the Immunohistochemistry Market in 2015
Figure 14 APAC to Witness the Highest Growth Rate During the Forecast Period
Figure 15 Developing Countries to Register Higher Growth in the Forecast Period
Figure 16 Immunohistochemistry Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Cancer Prevalence and Mortality Rate, By Country, 2012
Figure 18 Global Geriatric Population, By Region, 2010 vs 2015 vs 2030
Figure 19 Geriatric Population (65 Years & Above), By Country, 2010 vs 2015
Figure 20 Healthcare Spending (% of GDP), By Country, 2005 vs 2014
Figure 21 Comparative Cancer Mortality Rate (%) in Emerging Countries and Developed Countries, 2014
Figure 22 Market Consolidation & Incorporation of Nanotechnology in Immunohistochemistry are the Major Trends in the Market
Figure 23 Approach for Developing and Regulating Immunohistochemistry Products in the U.S.
Figure 24 Antibodies to Dominate the Immunohistochemistry Market During the Forecast Period
Figure 25 Primary Antibodies Segment to Dominate the Market During the Forecast Period
Figure 26 Immunohistochemistry Market, By Application (2016 vs 2021)
Figure 27 Immunohistochemistry Market for Diagnostic Applications (2016 vs 2021)
Figure 28 Hospitals and Diagnostic Laboratories End User Segment Will Continue to Dominate the Immunohistochemistry Market During the Forecast Period
Figure 29 Immunohistochemistry Market: Geographic Snapshot (2016-2021)
Figure 30 North America: Immunohistochemistry Market Snapshot
Figure 31 Europe: Immunohistochemistry Market Snapshot
Figure 32 Asia-Pacific: Immunohistochemistry Market Snapshot
Figure 33 Product Launches—Key Growth Strategy Adopted By Leading Players in the Immunohistochemistry Market Between 2013 and 2016
Figure 34 Global Immunohistochemistry Market Share Analysis, By Key Player, 2015
Figure 35 Battle for Market Share: Product Launch Was the Most Widely Adopted Strategy Between 2013 & 2016
Figure 36 Geographic Revenue Mix of the Top Five Players
Figure 37 Company Snapshot: F. Hoffmann-LA Roche AG
Figure 38 Company Snapshot: Danaher Corporation
Figure 39 Company Snapshot: Agilent Technologies, Inc.
Figure 40 Company Snapshot: Thermo Fisher Scientific Inc.
Figure 41 Company Snapshot: Merck Millipore
Figure 42 Company Snapshot: Bio-Rad Laboratories, Inc.
Figure 43 Company Snapshot: Perkinelmer, Inc.
Figure 44 Company Snapshot: Abcam PLC

The immunohistochemistry market is projected to reach USD 2.12 Billion by 2021, growing at a CAGR of 7.3% during the forecast period. Rising geriatric population, growing prevalence of chronic diseases, rapid technological developments in the IVD industry, and increasing healthcare spending are expected to fuel the growth of this market in the coming years. However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine are expected to offer significant growth opportunities for players in the market. Regulatory restrictions in developed countries, however, are a major challenge faced by market players in the current market.

The global immunohistochemistry market is segmented based on product, application, end user, and region. Based on product, the market is segmented into antibodies, reagents, equipment, and kits. Based on application, the global market is segmented into diagnostics and drug testing. The global market for diagnostic applications is further segmented into infectious diseases, cancer, cardiovascular diseases, diabetes mellitus, autoimmune diseases, and nephrological diseases. On the basis of end user the market is segmented into hospitals and diagnostics laboratories, research institutes, and other end users. This report also provides market information across major regional segments, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These regions are further segmented at a country level.

The antibodies segment accounted for the largest share of the global immunohistochemistry market, by product. On the other hand, the kits segment is expected to grow at the highest rate during the forecast period. Factors such as high demand for complete solutions from a single provider and advantages of kits such as ease of use, availability of ready-to-use reagents and antibodies, optimized sensitivity of the antibody to the antigen, and decreased chances of errors are driving the growth of this segment.

Immunohistochemistry Market

North America accounted for the largest share of the global immunohistochemistry market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Growth in the developed markets like North America and Europe is mainly driven by well-established healthcare industry, easy accessibility to advanced technologies, and growing opportunities for advanced cancer diagnostic testing and cancer screening. The demand in the APAC market is primarily driven by rising number of chronic diseases, rising standard of living, growing demand for quality medical care, increasing healthcare spending and government initiatives, and rising awareness on the use of immunohistochemistry tests.

The major players in the immunohistochemistry market are F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck Millipore (U.S.), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Abcam plc (U.K.), Cell Signaling Technology, Inc. (U.S.), and Bio SB Inc. (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo